BioCentury | Jun 18, 2019
Distillery Therapeutics

CAMKK2 identified as target for breast cancer

...cells to the tumor microenvironment, and a tool compound CAMKK2 inhibitor decreased tumor growth. TARGET/MARKER/PATHWAY: Calcium calmodulin-dependent protein kinase kinase 2 (CAMKK2)...
...Durham, N.C. email: luigi.racioppi@duke.edu CONTACT: Donald P. McDonnell, same affiliation as above email: Donald.McDonnell@duke.edu Claire Quang Duke University Calcium calmodulin-dependent protein kinase kinase 2 (CAMKK2) Breast...
BioCentury | May 2, 2013
Distillery Therapeutics

Indication: Neurology

...Publication and contact information Neurology Alzheimer's disease (AD) AMP-activated protein kinase (AMPK); b-amyloid 42 (Ab42); calcium calmodulin-dependent protein kinase kinase 2 (CAMKK2)...
Items per page:
1 - 2 of 2